Sponsor pipeline

ModeX Therapeutics, An OPKO Health Company clinical trial pipeline

Get alerts when ModeX Therapeutics, An OPKO Health Company's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
1
Phase 1/2
3

Disease areas by active trials, top 10 of 21

Bladder Cancer (1) · Breast Cancer (1) · Cervical Cancer (1) · Cholangiocarcinoma (1) · Colorectal Cancer (1) · DLBCL (1) · Endometrial Cancer (1) · Esophageal Cancer (1) · Follicular Lymphoma (1) · Gastric Cancer (1)

Get alerts when ModeX Therapeutics, An OPKO Health Company's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free